17 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
received post-graduate training at the Massachusetts General Hospital, Harvard Medical School and M.I.T.Dr. Pomerantz is Board Certified in both
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
University and his M.D. at the Johns Hopkins School of Medicine. Dr. Pomerantz received post-graduate training at the Massachusetts General Hospital, Harvard
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
. in Biochemistry at Johns Hopkins University and his M.D. at the Johns Hopkins School of Medicine. He received post-graduate training at Massachusetts General
20-F
9lntg h1h
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
zi5 m29tqufwdm92j
22 Sep 14
Bio Blast Pharma Announces Initiation of its Canadian OPMD Clinical Study Center at McGill University, Montreal
12:00am
424B4
ti85kpfuxl
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
ormbk5 0h1ow
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next